Jules Joel, Yang Shuying, Chen Wei, Li Yi-Ping
Department of Pathology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Department of Oral Biology, School of Dental Medicine, University at Buffalo, The State University of New York, Buffalo, New York, USA; Developmental Genomics Group, New York State Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA.
Prog Mol Biol Transl Sci. 2015;133:47-75. doi: 10.1016/bs.pmbts.2015.02.002. Epub 2015 Apr 27.
Regulators of G protein signaling (RGS) proteins enhance the intrinsic GTPase activity of α subunits of the heterotrimeric G protein complex of G protein-coupled receptors (GPCRs) and thereby inactivate signal transduction initiated by GPCRs. The RGS family consists of nearly 37 members with a conserved RGS homology domain which is critical for their GTPase accelerating activity. RGS proteins are expressed in most tissues, including heart, lung, brain, kidney, and bone and play essential roles in many physiological and pathological processes. In skeletal development and bone homeostasis as well as in many bone disorders, RGS proteins control the functions of various GPCRs, including the parathyroid hormone receptor type 1 and calcium-sensing receptor and also regulate various critical signaling pathways, such as Wnt and calcium oscillations. This chapter will discuss the current findings on the roles of RGS proteins in regulating signaling of key GPCRs in skeletal development and bone homeostasis. We also will examine the current updates of RGS proteins' regulation of calcium oscillations in bone physiology and highlight the roles of RGS proteins in selected bone pathological disorders. Despite the recent advances in bone and mineral research, RGS proteins remain understudied in the skeletal system. Further understanding of the roles of RGS proteins in bone should not only provide great insights into the molecular basis of various bone diseases but also generate great therapeutic drug targets for many bone diseases.
G蛋白信号调节蛋白(RGS)可增强G蛋白偶联受体(GPCR)异源三聚体G蛋白复合物α亚基的内在GTP酶活性,从而使GPCR启动的信号转导失活。RGS家族由近37个成员组成,具有保守的RGS同源结构域,该结构域对其GTP酶加速活性至关重要。RGS蛋白在包括心脏、肺、脑、肾和骨骼在内的大多数组织中表达,并在许多生理和病理过程中发挥重要作用。在骨骼发育、骨稳态以及许多骨骼疾病中,RGS蛋白控制着各种GPCR的功能,包括1型甲状旁腺激素受体和钙敏感受体,还调节各种关键信号通路,如Wnt和钙振荡。本章将讨论RGS蛋白在调节骨骼发育和骨稳态中关键GPCR信号传导方面的当前研究结果。我们还将研究RGS蛋白在骨生理学中对钙振荡调节的最新进展,并强调RGS蛋白在选定骨骼病理疾病中的作用。尽管在骨与矿物质研究方面取得了最新进展,但RGS蛋白在骨骼系统中的研究仍不足。进一步了解RGS蛋白在骨骼中的作用不仅应为各种骨疾病的分子基础提供深刻见解,还可为许多骨疾病产生重要的治疗药物靶点。